Skip to main content
Cornerstone Pharmaceuticals, Inc. Logo
  • About
  • Research and Development
    • CPI-613® (devimistat)
    • CB-839 (telaglenastat)
  • Leadership
    • Executive Management
    • Board of Directors
  • Contact Us
  • News & Investors
    • Press Releases
Clinical Trial Enrollment Contact Us
Investor/Media Kit
News & Investors
  • Press Releases

Investor/Media Kit Materials

  • Executive Management Bios
  • Cornerstone Pharma CPI-613 Factsheet
  • Cornerstone Pharma CB-839 Factsheet
Cornerstone Pharmaceuticals, Inc. Footer Logo
  • info@cornerstonepharma.com
  • Cornerstone Pharmaceuticals, Inc. 9 Deerpark Drive, Suit J-5
    Monmouth Junction, NJ 08852
Quick Links
  • Home
  • About
  • Research and Development
  • Leadership
© 2025 Cornerstone Pharmaceuticals, Inc. All Rights Reserved
  • Terms of Service
  • Privacy Policy
  • Terms of Use